12:00 AM
Jul 28, 2014
 |  BC Week In Review  |  Company News  |  Deals

Nicox, Rapid Pathogen Screening deal

Nicox said it has paid a total of $3 million to RPS in license and option fees and has contributed to half of the development costs of RPS-AP and RPS-OH. Under the amended agreement, Nicox will no longer contribute to development costs but may pay up to $525,000 in additional development milestones related to approval of...

Read the full 259 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >